estriol has been researched along with Movement Disorders in 1 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, IJ | 1 |
| Hopkins, IJ | 1 |
| Smith, MA | 1 |
1 other study available for estriol and Movement Disorders
| Article | Year |
|---|---|
Neurologic handicaps after low oestriol excretions in pregnancy.
Topics: Child; Estriol; Female; Fetal Diseases; Growth Disorders; Humans; Infant, Newborn; Movement Disorder | 1971 |